Folic Acid–Modified Long-Circulating Liposomes Loaded with Sulfasalazine For Targeted Induction of Ferroptosis in Melanoma
ACS Biomaterials Science & Engineering · 2024
DOI: 10.1021/acsbiomaterials.3c01223 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2024. Verfasst von Dong Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Affiliated Hospital of Weifang Medical University, Weifang 261031, China. Hauptthemen laut MEDLINE: Melanoma, Ferroptosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Doctoral Startup Fund of the Affiliated Hospital of Weifang Medical University.
Abstract (Originalsprache)
Melanoma is a malignant tumor that originates from melanocytes. The incidence of melanoma is increasing worldwide, partially because of its insensitivity to radiotherapy or chemotherapy. Therefore, effective treatments for melanoma are urgently required. In this study, we employed folic acid-modified sulfasalazine long-circulating liposomes (FA-SSZ-Lips) to precisely target drug delivery to melanoma cells, eliciting ferroptosis effectively. The synthesized FA-SSZ-Lips were characterized as small spheres of a double-layer membrane, a particle size of 110.1 nm, and a ζ-potential of -22.8 ± 0.66 mV. FA-SSZ-Lips are effective drug carriers with SSZ-loading ratio and SSZ release rate of 6.2 ± 0.10%, and 72.63 ± 1.40%, respectively. The liposomes enhanced SSZ solubility, and the folic acid modifications increased the liposome targeting to melanoma cells. Compared with SSZ alone, FA-SSZ-Lips more strongly inhibited B16F10 cell growth, significantly disrupted the intracellular redox balance, and induced ferroptosis. After treatment, considerable differences were observed in the tumor volumes between FA-SSZ-Lips and phosphate-buffered saline control groups. The tumor growth-inhibition value of the FA-SSZ-Lips group reached 70.09%. Thus, FA-SSZ-Lips exhibited favorable antitumor effects in vitro and in vivo and are a promising strategy for melanoma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Affiliated Hospital of Weifang Medical University, Weifang 261031, China.
ORCID-Profile: Weiyuan Ma
Förderung
- Doctoral Startup Fund of the Affiliated Hospital of Weifang Medical University
Zitieren
APA
Zhang, D., Zhang, M., Pang, Y., Li, M., & Ma, W. (2024). Folic Acid–Modified Long-Circulating Liposomes Loaded with Sulfasalazine For Targeted Induction of Ferroptosis in Melanoma. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.3c01223
Vancouver
Zhang D, Zhang M, Pang Y, Li M, Ma W. Folic Acid–Modified Long-Circulating Liposomes Loaded with Sulfasalazine For Targeted Induction of Ferroptosis in Melanoma. ACS Biomaterials Science & Engineering. 2024. doi:10.1021/acsbiomaterials.3c01223
BibTeX
@article{Zhang2024,
author = {Zhang, Dong and Zhang, Mogen and Pang, Yunyan and Li, Meiling and Ma, Weiyuan},
title = {Folic Acid–Modified Long-Circulating Liposomes Loaded with Sulfasalazine For Targeted Induction of Ferroptosis in Melanoma},
journal = {ACS Biomaterials Science & Engineering},
year = {2024},
doi = {10.1021/acsbiomaterials.3c01223}
}
EUVIMED